Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor - Pierce, M E; Chen, C.-y; Tillyer, R D (J. Org. Chem., 1998)
The DuPont Pharmaceuticals Company, Deepwater and Merck Research Laboratories, Rahway, USA